UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection

The Journal of clinical investigation, 2018-10, Vol.128 (10), p.4573-4587

2018

Volltextzugriff (PDF)

HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant

Gastroenterology (New York, N.Y. 1943), 2016-11, Vol.151 (5), p.986-998.e4

2016

Volltextzugriff (PDF)

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

The Journal of clinical investigation, 2018-10, Vol.128 (10), p.4588-4603

2018

Volltextzugriff (PDF)

Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1243-1252

2016

Volltextzugriff (PDF)

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver

PLoS pathogens, 2014-06, Vol.10 (6), p.e1004210

2014

Volltextzugriff (PDF)

Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells

Nature medicine, 2015-06, Vol.21 (6), p.591-600

2015

Volltextzugriff (PDF)

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B

Gut, 2021-12, Vol.70 (12), p.2337

2021

Volltextzugriff (PDF)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005788-e1005788

2016

Volltextzugriff (PDF)

The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells

PLoS pathogens, 2013-03, Vol.9 (3), p.e1003208-e1003208

2013

Volltextzugriff (PDF)

The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics

Journal of viral hepatitis, 2019-01, Vol.26 (1), p.4-15

2019

Volltextzugriff (PDF)

Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma

Cancers, 2022-02, Vol.14 (5), p.1255

2022

Volltextzugriff (PDF)

Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?

Viruses, 2022-04, Vol.14 (5), p.900

2022

Volltextzugriff (PDF)

The immune landscape in hepatitis delta virus infection—Still an open field

Journal of viral hepatitis, 2023-04, Vol.30 (S1), p.21-25

Gill, Upkar S.

2023

Volltextzugriff (PDF)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19

Frontiers in immunology, 2022-01, Vol.12, p.813300

2022

Volltextzugriff (PDF)

Pegylated interferon-α for chronic hepatitis B … not ready to be shelved yet! New insights on its role using single-cell transcriptomics

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.18-20

2024

Volltextzugriff (PDF)

Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies

JHEP reports, 2023-06, Vol.5 (6), p.100720-100720, Article 100720

2023

Volltextzugriff (PDF)

TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis

Scientific reports, 2017-07, Vol.7 (1), p.5514-11, Article 5514

2017

Volltextzugriff (PDF)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

Journal of hepatology, 2020-09, Vol.73 (3), p.705-708

2020

Volltextzugriff (PDF)

Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK

Frontiers in medicine, 2021-04, Vol.8, p.642723-642723

2021

Volltextzugriff (PDF)

HCMV jogs the ‘memory’ of NK cells in HBV

Journal of hepatology, 2019-03, Vol.70 (3), p.343-345

2019

Volltextzugriff (PDF)

Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.652-664

2020

Volltextzugriff (PDF)

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis

Gut, 2020-11, Vol.69 (11), p.1907

2020

Volltextzugriff (PDF)

Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus

Seminars in liver disease, 2017-05, Vol.37 (2), p.85

2017

Volltextzugriff (PDF)

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

The Journal of clinical investigation, 2018-02, Vol.128 (2), p.668-681

2018

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(58)
Humans
(45)
Gastroenterology & Hepatology
(30)
Hepatitis B
(29)
Hepatitis B Virus
(22)
Female
(21)
Adult
(20)
Male
(20)
Hepatitis
(18)
Infections
(18)
Liver
(17)
Hepatitis B, Chronic - Immunology
(15)
Middle Aged
(13)
Chronic Infection
(12)
Hepatitis B, Chronic - Drug Therapy
(12)
Liver Diseases
(12)
Lymphocytes
(12)
Antigens
(11)
Antiviral Agents - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection

HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver

Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells

The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics

Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma

Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?

The immune landscape in hepatitis delta virus infection—Still an open field

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19

Pegylated interferon-α for chronic hepatitis B … not ready to be shelved yet! New insights on its role using single-cell transcriptomics

Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies

TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK

HCMV jogs the ‘memory’ of NK cells in HBV

Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis

Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

Suchergebnisse filtern